Conn Vicki S, Ruppar Todd M, Enriquez Maithe, Cooper Pam
Sinclair School of Nursing, University of Missouri, Columbia, MO 65211, USA.
Sinclair School of Nursing, University of Missouri, Columbia, MO 65211, USA.
Res Social Adm Pharm. 2016 Mar-Apr;12(2):218-46. doi: 10.1016/j.sapharm.2015.06.001. Epub 2015 Jun 15.
Inadequate medication adherence is a pervasive, under-recognized cause of poor health outcomes. Many intervention trials designed to improve medication adherence have targeted adults with adherence problems. No previous reviews have synthesized the effectiveness of medication adherence interventions focused on subjects with medication adherence difficulties.
This systematic review and meta-analysis synthesized findings from medication adherence intervention studies conducted among adults with medication adherence difficulties.
Primary research studies were eligible for inclusion if they tested an intervention designed to increase medication adherence among adults with documented adherence difficulties and reported medication adherence behavior outcomes. Comprehensive search strategies of 13 computerized databases, author and ancestry searches, and hand searches of 57 journals were used to locate eligible primary research. Participant demographics, intervention characteristics, and methodological features were reliably coded from reports along with medication adherence outcomes. Effect sizes for outcomes were calculated as standardized mean differences, and random effects models were used to estimate overall mean effects. Exploratory dichotomous and continuous variable moderator analyses were employed to examine potential associations between medication adherence effect size and sample, intervention, and methodological characteristics.
Data were extracted from 53 reports of studies involving 8243 individual primary study participants. The overall standardized mean difference effect size for treatment vs. control subjects was 0.301. For treatment pre- vs. post-intervention comparisons, the overall effect size was 0.533. Significantly larger effect sizes were associated with interventions incorporating prompts to take medications than interventions lacking medication prompts (0.497 vs. 0.234). Larger effect sizes were also found for interventions that linked medication taking with existing habits compared to interventions that did not (0.574 vs. 0.222). Effect sizes were largest among studies that measured adherence by pill counts or electronic event monitoring systems. Analysis of study design features identified several potential risks of bias. Statistically significant publication bias was detected, but adherence effect sizes were not significantly associated with other risks of bias.
These findings document that interventions targeting individuals with medication adherence problems can have modest but significant effects on medication-taking behavior. The findings support the use of behavioral strategies such as prompts and linking medications to habits to increase medication adherence in adults with adherence challenges. Face-to-face interventions appear to be critical for patients who have experienced past problems with medication adherence.
药物治疗依从性不足是导致健康状况不佳的一个普遍存在但未得到充分认识的原因。许多旨在提高药物治疗依从性的干预试验都针对有依从性问题的成年人。以前没有综述综合过针对有药物治疗依从性困难的受试者的药物治疗依从性干预措施的有效性。
本系统综述和荟萃分析综合了在有药物治疗依从性困难的成年人中进行的药物治疗依从性干预研究的结果。
如果初级研究测试了旨在提高有记录的依从性困难的成年人的药物治疗依从性的干预措施,并报告了药物治疗依从性行为结果,则这些研究有资格纳入。使用13个计算机化数据库的全面检索策略、作者检索和溯源检索以及对57种期刊的手工检索来查找符合条件的初级研究。从报告中可靠地编码参与者的人口统计学特征、干预特征和方法学特征以及药物治疗依从性结果。结果的效应大小以标准化均值差异计算,并使用随机效应模型估计总体平均效应。采用探索性二分法和连续变量调节分析来检验药物治疗依从性效应大小与样本、干预和方法学特征之间的潜在关联。
从涉及8243名个体初级研究参与者的53项研究报告中提取数据。治疗组与对照组受试者的总体标准化均值差异效应大小为0.301。对于治疗前与治疗后的比较,总体效应大小为0.533。与缺乏药物提示的干预措施相比,纳入服药提示的干预措施的效应大小显著更大(0.497对0.234)。与未将服药与现有习惯联系起来的干预措施相比,将服药与现有习惯联系起来的干预措施也发现了更大的效应大小(0.574对0.222)。在通过药丸计数或电子事件监测系统测量依从性的研究中,效应大小最大。对研究设计特征的分析确定了几个潜在的偏倚风险。检测到具有统计学意义的发表偏倚,但依从性效应大小与其他偏倚风险没有显著关联。
这些研究结果表明,针对有药物治疗依从性问题的个体的干预措施可以对服药行为产生适度但显著的影响。这些发现支持使用提示和将药物与习惯联系起来等行为策略,以提高有依从性挑战的成年人的药物治疗依从性。面对面干预对于过去有药物治疗依从性问题的患者似乎至关重要。